1Thanvi BR, Munshi SK, Vijaykumar N, et al. Neuropsychiatric non-motor aspects of Parkinson ' s disease. Postgrad Med J, 2003, 79: 561-565.
2Slaughter JR, Slaughter KA, Nichols D, et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson' s disease. J Neuropsychiatry Clin Neurosci, 2001, 13(2): 187-196.
3Mcdonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson ' s disease. Biol Psychiatry, 2003 , 54 (3) : 363 -375.
4Thanvi BR, Munshi SK, Vijaykumar N, et al. Neuropsychiatric non- motor aspects of Parkinson ' s disease. Postgrad Med J, 2003, 79(936) : 561-565.
5Hanagasi HA, Emre M. Management of the neuropsychiatric and cognitive symptoms in Parkinson' s disease. Practical Neurology, 2002, 2 : 94-102.
7Aarland D, Larsen JP, Goek Lim N, et al. Range of neuropsychiatric disturbances in patients with parkinson' s disease. J Neurol Neurosurg Psychiatry, 1999, 67 (4) : 492-496.
8Kirsch-Darrow L, Fernandes HF, Marsiske M, et al. Dissociating apathy and depression in Parkinson disease. Neurology, 2006, 67(7) : 33-38.
9Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry, 1990, 147: 22-30.
10Richard IH. Apathy does not equal depression in Parkinson ' s disease: Why we should care? Neurology, 2006, 67 (1) : 10-11 .
二级参考文献31
1汪向东.心理卫生评定量表手册[J].中国心理卫生杂志,1993,:202-209.
2Ziegler M,Castro-Caldas A,Del Signore S,et al.Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease:a 6-month,randomized,placebo-controlled study[J].Mov Disord,2003,18:418-425
4Hughes AJ,Daniel SE,Kilford L,et al.Accuracy of clinical diagnosis of idiopathic Parkinson's diseases; A clinical pathological study of 100 cases[J].J Neurol Neurosurg Psychiatry,1992,55:181-184
5Hoehn MM,Yahr MD.Parkinsonism onset progression and mortality[J].Neurology,1967,17:427-442
6陈海波.统一帕金森评定量表.中华老年医学杂志,1999,18:61-62.
7Chaudhuri KR,Pal S,DiMarco A,et al.The Parkinson's disease sleep scale:a new instrument for assessing sleep and nocturnal disability in Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2002,73:629-635
8Boer AG,Wijker W,Speelman JD,et al.Quality of life in patients with Parkinson's disease:development of a questionnaire[J].J Neurol Neurosurg Psychiatry,1996,61:70-74
9Rascol O,Brooks DJ,Korczyn AD,et al.A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa[J].N Engl J Med,2000,342:1484-1491
10Hubble JP.Long-term studies of dopamine agonists[J].Neurology,2002,58(suppl):42-57
6Kummer A, Teixeira AL. Neuropsychiatry of Parkinson ' s Disease. Arq Neuropsiquiatr, 2009, 67 (3-B): 930- 939.
7Starkstein SE, Leentjens AF. The nosological position of apa- thy in clinical practice. J Neurol Neurosurg Psychiatry, 2008, 79(10) : 1088-1092.
8Reijnders JS, Ehrt U, Weber WE, et al. A systematic re- view of prevalence studies of depression in Parkinson ' s dis- ease. Mov Disord, 2008, 23(2) : 183-189.
9Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkin- son's disease. Brain, 2008, 131 (Pt 10): 2720- 2728.
10Arabia G, Grossardt BR, Geda YE, et al. Increased risk of depressive and anxiety disorders in relative of patients with Parkinson disease. Arch Gen Psychiatry, 2007 , 64 ( 12 ) : 1385-1392.
